Phase 1 Trial of Mutant proUK, M5, and Its Inhibitor, C1-inhibitor

Trial Profile

Phase 1 Trial of Mutant proUK, M5, and Its Inhibitor, C1-inhibitor

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs TS 01 (Primary) ; M-5
  • Indications Stroke; Thrombosis
  • Focus Adverse reactions; First in man
  • Sponsors Thrombolytic Science International
  • Most Recent Events

    • 18 Sep 2017 Status changed from suspended to completed, according to a Thrombolytic Science media release.
    • 12 Jan 2015 Planned End Date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
    • 12 Jan 2015 Planned primary completion date changed from 1 Jan 2013 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top